摘要
背景:近年来,许多研究都致力于生物标志物在心力衰竭领域的应用。 目的:研究microRNAs转录后在心力衰竭诊断和治疗中的调控作用。 方法:文献检索集中在microRNAs在心力衰竭中的作用。 结果:microRNAs在心衰病理表现过程中表达和调控。这一广泛而未知的遗传印记领域由小的非编码RNA分子组成,在特定条件或压力下,这些基因印记会被上调,并从器官释放到血液中。使用基于基因的策略治疗心衰在生物医学领域引起了极大的兴趣,因为它们可以作为生物标志物,提供有关心脏状态和功能的信息。由于它们能够在不改变基因序列的情况下诱导细胞水平的变化,因此它们似乎也是具有治疗潜力的有前途的工具。此外,随着microRNAs鉴定技术的基因组测序、量化和合成技术的进步,以及对microRNAs生物学及其在HF中的作用的研究进展,microRNAs有望用于HF患者并对其预后产生良好的影响。 结论:MicroRNAs参与了心力衰竭进展的多生物学过程的调控。需要更多的研究来实现microRNAs在心衰治疗中的临床应用价值。
关键词: 心脏纤维化,心肌细胞,心脏重塑,炎症,细胞治疗,再生。
Current Medicinal Chemistry
Title:MicroRNAs in the Management of Heart Failure
Volume: 28 Issue: 24
关键词: 心脏纤维化,心肌细胞,心脏重塑,炎症,细胞治疗,再生。
摘要:
Background: In recent years much research has been devoted to the deployment of biomarkers in the field of heart failure.
Objectives: To study the potential of post-transcriptional regulation by microRNAs on the diagnosis, management and therapy of heart failure.
Methods: Literature search focuses on the role of microRNAs in heart failure.
Results: MicroRNAs are expressed and regulated in the course of the pathological manifestations of heart failure (HF). This wide and uncharted area of genetic imprints consisting of small non-coding RNA molecule is upregulated and released into the bloodstream from organs under certain conditions and or stress. The use of genetically based strategies for the management of HF has gained great interest in the field of biomedical science because they can be used as biomarkers providing information regarding cardiac status and function. They also appear as promising tools with therapeutic potential because of their ability to induce changes at the cellular level without creating alterations in the gene sequence. In addition, with the advances in genomic sequencing, quantification and synthesis in technologies of microRNAs identification as well as the growing knowledge of the biology of miRNAs and their involvement in HF, it is expected to favorably affect the prognosis of HF patients.
Conclusion: MicroRNAs are involved in the regulation of multibiological processes involved in the progress of heart failure. More studies are needed to achieve a clinical valuable implementation of microRNAs in the management of HF.
Export Options
About this article
Cite this article as:
MicroRNAs in the Management of Heart Failure, Current Medicinal Chemistry 2021; 28 (24) . https://dx.doi.org/10.2174/0929867328666210218181441
DOI https://dx.doi.org/10.2174/0929867328666210218181441 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the Treatment of Chronic Inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Organoid Models of Heart Diseases: Find a New Channel in Improvements
of Cardiac Regenerative Medicine
Current Medicinal Chemistry Interrelationship between Chronic Kidney Disease and Risk of Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Matrix Metalloproteinases in Acute Coronary Syndromes: Current Perspectives
Current Topics in Medicinal Chemistry Biomarkers in Acute Heart Failure Syndromes: An Update
Current Cardiology Reviews Chronic Obstructive Pulmonary Disease and Sleep Disordered Breathing - The Overlap Syndrome: An Evolving Clinical Phenotype
Current Respiratory Medicine Reviews Scientific Papers and Patents on Substances with Unproven Effects. Part 2
Recent Patents on Drug Delivery & Formulation Therapeutical Relevance of MAP-Kinase Inhibitors in Renal Diseases: Current Knowledge and Future Clinical Perspectives
Current Medicinal Chemistry The Role of Exercise-based Cardiac Rehabilitation in Heart Failure
Current Pharmaceutical Design Preface [Hot Topic: Oxidative Balance: From Chemistry to Clinical Medicine (Executive Editor: Fortunato Vesce)]
Current Pharmaceutical Design Assessing Systemic Arterial Hypertension Through Echocardiography: A Review for the Clinician
Current Hypertension Reviews Conivaptan: Potential Therapeutic Implications in Heart Failure
Recent Patents on Cardiovascular Drug Discovery Drugs Affecting Blood Pressure Variability: An Update
Current Pharmaceutical Design Calcium and Vitamin D Supplementation. Myths and Realities with Regard to Cardiovascular Risk
Current Vascular Pharmacology Incremental Value of Two Dimensional Speckle Tracking Echocardiography in the Functional Assessment and Characterization of Subclinical Left Ventricular Dysfunction
Current Cardiology Reviews Protective Effects of Intermedin On Cardiovascular, Pulmonary and Renal Diseases: Comparison with Adrenomedullin and CGRP
Current Protein & Peptide Science Hypertension and Childhood Obesity: A Whirling Tango. A Review of the Dance Steps
Current Hypertension Reviews Perinatal Brain Injury
Current Pediatric Reviews Hypothyroidism and Cardiovascular Disease: Factors, Mechanism and Future Perspectives
Current Medicinal Chemistry Recent Patents on Cardiovascular Stem Cells
Recent Patents on Cardiovascular Drug Discovery Role of Genomic Alterations in HER2 Positive Breast Carcinoma: Focus on Susceptibility and Trastuzumab-therapy
Current Cancer Drug Targets